The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
DPX-Survivac, a novel T-cell immunotherapy, to induce robust T-cell responses in advanced ovarian cancer.
 
Oliver Dorigo
Consulting or Advisory Role - Clovis Oncology; Geneos; Merck; Tesaro
Speakers' Bureau - AstraZeneca; Tesaro
 
Stephan Fiset
Employment - IMV
Stock and Other Ownership Interests - IMV
Patents, Royalties, Other Intellectual Property - Immune Cell Therapy
 
Lisa Diana MacDonald
Employment - IMV
Stock and Other Ownership Interests - IMV
Patents, Royalties, Other Intellectual Property - Immune Cell Therapy
 
Yogesh Bramhecha
Employment - IMV
Stock and Other Ownership Interests - IMV
 
Olga Hrytsenko
Employment - IMV
Stock and Other Ownership Interests - IMV
 
Brennan Dirk
Employment - IMV
 
Gabriela Nicola Rosu
Employment - Immunovaccine
Leadership - Immunovaccine
Stock and Other Ownership Interests - Immunovaccine
Patents, Royalties, Other Intellectual Property - I am employed and own stock options in Immunovaccine Inc which owns Depovax and DPX Survivac
Travel, Accommodations, Expenses - Immunovaccine
 
Marianne Stanford
Employment - Immunovaccine
Stock and Other Ownership Interests - Immunovaccine
Patents, Royalties, Other Intellectual Property - DNAtrix; patent royalties paid; Immunovaccine